The XENERA ™-1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Post-menopausal Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

Condition:   Breast Neoplasms Interventions:   Drug: Xentuzumab;   Drug: Placebo;   Drug: Everolimus;   Drug: Exemestane Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials